Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about SRPT

Recent news which mentions SRPT

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Sarepta Therapeutics Stock Has 73% Upside, According to 1 Wall Street Analyst
Tickers SRPT
Tags Market News Recent Press Releases SRPT
From Motley Fool
Sarepta Therapeutics (SRPT) Q4 2023 Earnings Call Transcript
Tickers SRPT
Tags Market News Recent Press Releases SRPT
From Motley Fool
Sarepta Therapeutics: Q4 Earnings Insights
Tickers SRPT
Tags Benzinga SRPT BZI/Recaps
From Benzinga
Is It Too Late to Buy Sarepta Therapeutics Stock?
Tickers SRPT
Tags Recent Press Releases SRPT Market News
From Motley Fool
Earnings Scheduled For February 28, 2024
Tickers NOVT NRG NSA NTNX
Tags SQSP VST ZUO
From Benzinga
A Preview Of Sarepta Therapeutics's Earnings
Tickers SRPT
Tags SRPT Benzinga Market News
From Benzinga
Median Drug Prices For Rare Diseases Hit $300K In 2023, Report Highlights Lack of Clear Rationale Behind Escalating Drug Prices
Tickers CRSP NEWS REGN SRPT
Tags Stories That Matter CRSP Biotech
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers ARQT IOVA LLY MDT
Tags MRNA BZI/AUOA Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Tickers AMIX AMN AORT BCLI
Tags CLDI SXTC AMIX
From Benzinga
FDA Fast-Tracks Review Of Sarepta's Groundbreaking Muscular Dystrophy Treatment With $1B Market In Sight
Tickers NEWS RHHBY SRPT
Tags News Trading Ideas Large Cap
From Benzinga
Why DoorDash Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Tickers AMAT AMBO AMN AORT
Tags Markets AMBO Market News
From Benzinga
Why Sarepta Therapeutics Stock Is Soaring Today
Tickers SRPT
Tags Market News Recent Press Releases SRPT
From Motley Fool
Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday
Tickers AMAT AORT BIO BLZE
Tags TTD big gainers DTM
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Tickers AMN AORT CDIO HCTI
Tags SXTC Movers Market News
From Benzinga
In-Depth Examination Of 13 Analyst Recommendations For Sarepta Therapeutics
Tickers SRPT
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
2 Magnificent Growth Stocks to Buy With $500
Tickers SRPT VEEV
Tags Recent Press Releases SRPT VEEV
From Motley Fool
Gene Therapy Player REGENXBIO's RGX-121 Marks Success In Trial, Yet Faces Challenges In A Crowded Market: Analyst
Tickers DNLI NEWS PFE RGNX
Tags Benzinga General Analyst Ratings
From Benzinga
1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock?
Tickers PTCT SRPT
Tags PTCT Market News SRPT
From Motley Fool
The Top 25 Stocks to Buy Immediately According to AI: February 2024 Edition
Tickers ADP AJG AMGN AMH
Tags HESS REGN APP
From InvestorPlace
Assessing Sarepta Therapeutics: Insights From 12 Financial Analysts
Tickers SRPT
Tags SRPT Benzinga Market News
From Benzinga
Sarepta Therapeutics' Next-Gen Duchenne Muscular Therapy Shows Efficacy At Less Frequent Dosing
Tickers NEWS SRPT
Tags Market News Equities Biotech
From Benzinga
Got $3,000? 3 Growth Stocks to Double Up On Right Now
Tickers SRPT SYM UBER
Tags SYM Market News UBER
From Motley Fool
Could Sarepta Therapeutics Become the Next Vertex Pharmaceuticals?
Tickers SRPT VRTX
Tags Market News VRTX Recent Press Releases
From Motley Fool
Why Sarepta Therapeutics Stock Zoomed Nearly 5% Higher Today
Tickers JPM SRPT
Tags Recent Press Releases SRPT Market News
From Motley Fool
Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market
Tickers ATOS SRPT UTHR
Tags NASDAQ:SRPT,NASDAQ:ATOS,NASDAQ:UTHR ATOS SRPT
From InvestorPlace
A Closer Look at 14 Analyst Recommendations For Sarepta Therapeutics
Tickers SRPT
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
Stocks Flip To Losses, Nvidia Defies Gravity, Bitcoin Pauses For A Breather: What's Driving Markets Tuesday?
Tickers AMD BA BITCOMP DIA
Tags midday update Sector ETFs NVDA
From Benzinga
Sarepta Expects Prelim Gene Therapy Revenue To Be $131M In Q4, $200M For Fiscal Year
Tickers NEWS SRPT
Tags News Analyst Color Health Care
From Benzinga
Bumble (BMBL) Stock Pops as Elliott Builds a Stake in Rival Match
Tickers BMBL GRFS MTCH RENT
Tags Today's Market RENT NASDAQ:BMBL,NASDAQ:MTCH,NASDAQ:GRFS,NASDAQ:SRPT,NASDAQ:RENT
From InvestorPlace
Why Is Sarepta Therapeutics (SRPT) Stock Up Today?
Tickers JNPR RENT RKLB SRPT
Tags RKLB Today's Market JNPR
From InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.